SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-21-002825
Filing Date
2021-11-03
Accepted
2021-11-03 16:11:47
Documents
63
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q crsp-20210930.htm   iXBRL 10-Q 2658884
2 EX-31.1 crsp-ex31_1.htm EX-31.1 13576
3 EX-31.2 crsp-ex31_2.htm EX-31.2 13582
4 EX-32.1 crsp-ex32_1.htm EX-32.1 12511
  Complete submission text file 0000950170-21-002825.txt   9809458

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT crsp-20210930_cal.xml EX-101.CAL 51683
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT crsp-20210930_def.xml EX-101.DEF 185091
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crsp-20210930_lab.xml EX-101.LAB 443053
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crsp-20210930_pre.xml EX-101.PRE 304985
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crsp-20210930.xsd EX-101.SCH 53697
10 EXTRACTED XBRL INSTANCE DOCUMENT crsp-20210930_htm.xml XML 2163761
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37923 | Film No.: 211375474
SIC: 2836 Biological Products, (No Diagnostic Substances)